FDA Enforcement · Apr 22, 2026
Drug recall: Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx…
Lack of Assurance of Sterility — Huons Co., Ltd. · Class II · Ongoing
Latest medical news · page 261
The latest headlines across every section, pulled from official and open-access sources.
FDA Enforcement · Apr 22, 2026
Drug recall: Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API),…
Subpotent drug — Avantor Performance Materials LLC · Class III · Ongoing
FDA Enforcement · Apr 22, 2026
Drug recall: Lidocaine HCl injection, USP, 1% 50mg/5mL (10 mg/mL), 5 mL Single Dose Vials, Rx only, Manufactured by:…
Lack of Assurance of Sterility — Huons Co., Ltd. · Class II · Ongoing
FDA Enforcement · Apr 22, 2026
Drug recall: QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops, Menthol Flavor, 30-count bag,…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality. — Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · Class II · Ongoing
FDA Enforcement · Apr 22, 2026
Drug recall: HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 FL OZ/60ml spray bottle;…
Chemical contamination: Presence of benzene — Owen Biosciences Inc. · Class II · Ongoing
FDA Enforcement · Apr 22, 2026
Drug recall: Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC…
Failed Stability Specifications — Island Kinetics, Inc. d.b.a. CoValence Laboratories · Class II · Ongoing
FDA Enforcement · Apr 22, 2026
Drug recall: MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Honey Lemon, 80-count bag,…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality. — Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · Class II · Ongoing
FDA Enforcement · Apr 22, 2026
Drug recall: Lidocaine HCl Injection, USP, 2%, 100 mg/5mL (20 mg/mL), 5 mL Single-Dose Vials, Rx only, Manufactured by:…
Lack of Assurance of Sterility — Huons Co., Ltd. · Class II · Ongoing
FDA Enforcement · Apr 22, 2026
Drug recall: QC Quality Choice, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Cherry Flavor, 30-count bag,…
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality. — Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · Class II · Ongoing
Drugs@FDA · Apr 22, 2026
FDA expands Dupixent (dupilumab) approval
Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Regeneron Pharmaceuticals
Annals On Call (ACP) · Apr 20, 2026
Physicians Not Providers
Dr. Centor discusses why the American College of Physicians believes that physicians should not be called providers with Drs. Robert McLean and Jan Carney.
FDA Newsroom · Apr 20, 2026
FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development
Since publishing roadmap last April, agency has successfully launched several key initiatives to replace animal testing with better alternatives
JAMA Clinical Reviews · Apr 20, 2026
Prepregnancy Care and Counseling to Improve Maternal and Neonatal Outcomes
In the US, approximately 66% of reproductive-aged women have at least 1 modifiable risk factor for adverse pregnancy outcomes. Authors and ob-gyns Kylie Cooper, MD, and Daniel Breitkopf, MD, both from the Mayo Clinic, discuss ways to reduce maternal morbidity and mortality and improve neonatal outcomes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content: Prepregnancy Care and Counseling
Drugs@FDA · Apr 20, 2026
FDA expands Tzield (teplizumab-mzwv) approval
Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Provention Bio Inc
CDC Newsroom · Apr 20, 2026
CDC Disease Detectives Present at Annual CDC EIS Conference
CDC's Epidemic Intelligence Service officers are gathering this week for the 2026 EIS Conference
AFP Podcast (AAFP) · Apr 16, 2026
Episode 251 | April 2026 | Part 1 American Family Physician
Vaccine adverse effects (1:30), vaccine conversations (5:10), beta blockers after myocardial infarction (8:10), thrombocytosis (10:40), drowning (14:10), and HPV vaccine (16:00).
CDC MMWR · Apr 16, 2026
Notes from the Field: Tetanus in Four Children - Idaho, Minnesota, Missouri, and Wisconsin, 2024
This report describes four cases of tetanus among children who had not received a primary tetanus toxoid-containing virus series before exposure.
CDC MMWR · Apr 16, 2026
Clusters of Invasive Haemophilus influenzae Type b Disease Among Adults Using Substances or Experiencing Homelessness or Housing Instability - Alaska, Oregon, and Washington, 2023─2025
This report describes two clusters of invasive of Haemophilus influenzae type b among adults with special risk factors in Alaska, Oregon, and Washington.
NEJM This Week · Apr 15, 2026
NEJM This Week — April 16, 2026
This week, we present new research on stroke prevention, Kawasaki disease, ICU infection strategies, and immune thrombocytopenia. We review hormone therapy and thrombotic risk. A case highlights an evolving diagnosis of severe fatigue and sleep disturbance. Perspectives explore nursing workforce policy, the role of nurse scientists in rebuilding trust, and the health consequences of environmental rollbacks.
NCQA · Apr 14, 2026
NCQA Is Launching a New Data Quality Solution for Digital HEDIS® and Seeks Beta Partners
As the healthcare industry moves toward interoperability, health plans are using more clinical data in HEDIS® reporting. Clinical data come from many sources: care delivery organizations, health information exchanges, qualified health information networks and vendors. As the volume and complexity of clinical data used in HEDIS evolve, organizations need more scalable ways to evaluate whether […] The post NCQA Is Launching a New Data Quality Solution for Digital HEDIS® and Seeks Beta Partners appeared first on NCQA .
CDC MMWR · Apr 14, 2026
Surveillance Summaries: Tetanus Surveillance - United States, 2009-2023
This report describes tetanus surveillance in the United States from 2009-2023
JAMA Clinical Reviews · Apr 13, 2026
Diagnosis and Management of Endometrial Cancer
Endometrial cancer accounts for 95% of uterine cancers, which are the fourth most common cancer in women in the US. Author Karen McLean, MD, PhD, of Roswell Park Comprehensive Cancer Center joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about diagnosis and treatment of endometrial cancer. Related Content: Endometrial Cancer
CDC MMWR · Apr 9, 2026
Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024
This report describes severe illness associated with eating mushroom-containing chocolate products.
CDC MMWR · Apr 9, 2026
Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023
This report describes the emergence of drug-resistant shigellosis in the United States during 2011-2023.